Early intensive glycaemic control in type 2 diabetes provides near-lifelong protection, study finds
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Stay updated with breaking news from Remission Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Read this article to find out what can be done to induce remission in type 2 diabetes and how to treat and manage the condition
Using routinely collected primary and secondary care data, Karen D Coulman and colleagues investigate how access to weight management services varies across England.
Tens of thousands of people in England living with early onset type 2 diabetes will benefit from more intensive and targeted care, thanks to a world-first initiative being rolled out by the NHS.
Tens of thousands of people in England living with the condition will receive tailored health checks and support with diabetes management such as blood sugar level control and weight advice.